Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s400249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Ping Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Cardiomyopathies, MicroRNAs, Membrane Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China.
- Department of Endocrinology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225001, People's Republic of China.
Zitieren
APA
Fang, P., Ye, Z., Li, R., She, D., Zong, G., Zhang, L., Xue, Y., & Zhang, K. (2023). Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s400249
Vancouver
Fang P, Ye Z, Li R, She D, Zong G, Zhang L, et al. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s400249
BibTeX
@article{Fang2023,
author = {Fang, Ping and Ye, Zhengqin and Li, Ran and She, Dunmin and Zong, Guannan and Zhang, Liya and Xue, Ying and Zhang, Keqin},
title = {Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s400249}
}
EUVIMED